Praxis Precision Medicines Stock Today
PRAX Stock | USD 71.87 0.86 1.18% |
Performance11 of 100
| Odds Of DistressLess than 28
|
Praxis Precision is trading at 71.87 as of the 7th of November 2024; that is 1.18 percent decrease since the beginning of the trading day. The stock's open price was 72.73. Praxis Precision has about a 28 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. Equity ratings for Praxis Precision Medicines are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of October 2024 and ending today, the 7th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 16th of October 2020 | Category Healthcare | Classification Health Care |
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 17.76 M outstanding shares of which 1.72 M shares are at this time shorted by private and institutional investors with about 5.84 trading days to cover. More on Praxis Precision Medicines
Moving together with Praxis Stock
Moving against Praxis Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Praxis Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
CEO President | Marcio MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPraxis Precision can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Praxis Precision's financial leverage. It provides some insight into what part of Praxis Precision's total assets is financed by creditors.
|
Praxis Precision Medicines (PRAX) is traded on NASDAQ Exchange in USA. It is located in 99 High Street, Boston, MA, United States, 02110 and employs 82 people. Praxis Precision is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.29 B. Praxis Precision Med conducts business under Biotechnology sector and is part of Health Care industry. The entity has 17.76 M outstanding shares of which 1.72 M shares are at this time shorted by private and institutional investors with about 5.84 trading days to cover.
Praxis Precision Medicines currently holds about 165.4 M in cash with (111.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7.
Check Praxis Precision Probability Of Bankruptcy
Ownership AllocationThe majority of Praxis Precision Medicines outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Praxis Precision Med to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Praxis Precision. Please pay attention to any change in the institutional holdings of Praxis Precision Med as this could imply that something significant has changed or is about to change at the company.
Check Praxis Ownership Details
Praxis Stock Institutional Holders
Instituion | Recorded On | Shares | |
Soleus Capital Management, L.p. | 2024-06-30 | 533 K | |
Partner Fund Management Lp | 2024-06-30 | 453.1 K | |
Vestal Point Capital Lp | 2024-06-30 | 440 K | |
Kingdon Capital Management Llc | 2024-06-30 | 415 K | |
Geode Capital Management, Llc | 2024-06-30 | 395.1 K | |
Deep Track Capital, Lp | 2024-06-30 | 389.5 K | |
Hhg Plc | 2024-06-30 | 381.7 K | |
Morgan Stanley - Brokerage Accounts | 2024-06-30 | 368.6 K | |
Velan Capital Investment Management Lp | 2024-06-30 | 350.7 K | |
Blackrock Inc | 2024-06-30 | 1.3 M | |
Ra Capital Management, Llc | 2024-06-30 | 1.2 M |
Praxis Precision Historical Income Statement
Praxis Stock Against Markets
Praxis Precision Corporate Management
Dr B | CoFounder Officer | Profile | |
Timothy Kelly | CFO Treasurer | Profile | |
Nicole Sweeny | Chief Officer | Profile | |
Kelly McCue | Chief Officer | Profile | |
Alyssa Wyant | Chief Officer | Profile | |
Megan Sniecinski | Chief Officer | Profile | |
Lauren Mastrocola | VP Officer | Profile |
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.